XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Deficit)
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Noncontrolling Interest
Beginning Balance (in shares) at Dec. 31, 2023   516,775,000          
Beginning Balance at Dec. 31, 2023 $ 4,820,681 $ 5,166 $ 6,407,294 $ 57,035 $ 472 $ (1,657,675) $ 8,389
Net income (loss) 51,706     51,235     471
Foreign currency translation adjustment (993)       (993)    
Vesting of restricted stock units (in shares)   1,363,000          
Vesting of restricted stock units 0 $ 14 (14)        
Stock-based compensation 12,051   12,051        
Payment of cash dividends (32,553)     (32,553)      
Dividend equivalents (422)     (422)      
Purchase of treasury stock (98,613)         (98,613)  
Ending Balance (in shares) at Mar. 31, 2024   518,138,000          
Ending Balance at Mar. 31, 2024 4,751,857 $ 5,180 6,419,331 75,295 (521) (1,756,288) 8,860
Beginning Balance (in shares) at Dec. 31, 2023   516,775,000          
Beginning Balance at Dec. 31, 2023 4,820,681 $ 5,166 6,407,294 57,035 472 (1,657,675) 8,389
Net income (loss) (915,007)            
Foreign currency translation adjustment (523)            
Ending Balance (in shares) at Sep. 30, 2024   520,742,000          
Ending Balance at Sep. 30, 2024 3,571,958 $ 5,207 6,443,043 (956,173) (51) (1,929,899) 9,831
Beginning Balance (in shares) at Mar. 31, 2024   518,138,000          
Beginning Balance at Mar. 31, 2024 4,751,857 $ 5,180 6,419,331 75,295 (521) (1,756,288) 8,860
Net income (loss) 11,621     11,077     544
Foreign currency translation adjustment (127)       (127)    
Issuance of restricted stock (in shares)   719,000          
Issuance of restricted stock 0 $ 8 (8)        
Vesting of restricted stock units (in shares)   1,647,000          
Vesting of restricted stock units 0 $ 17 (17)        
Stock-based compensation 10,813   10,813        
Payment of cash dividends (31,815)     (31,815)      
Dividend equivalents (348)     (348)      
Purchase of treasury stock (133,487)         (133,487)  
Ending Balance (in shares) at Jun. 30, 2024   520,504,000          
Ending Balance at Jun. 30, 2024 4,608,514 $ 5,205 6,430,119 54,209 (648) (1,889,775) 9,404
Net income (loss) (978,334)     (978,761)     427
Foreign currency translation adjustment 597       597    
Vesting of restricted stock units (in shares)   238,000          
Vesting of restricted stock units 0 $ 2 (2)        
Stock-based compensation 12,926   12,926        
Payment of cash dividends (31,225)     (31,225)      
Dividend equivalents (396)     (396)      
Purchase of treasury stock (40,124)         (40,124)  
Ending Balance (in shares) at Sep. 30, 2024   520,742,000          
Ending Balance at Sep. 30, 2024 $ 3,571,958 $ 5,207 6,443,043 (956,173) (51) (1,929,899) 9,831
Beginning Balance (in shares) at Dec. 31, 2024 520,784,783 520,785,000          
Beginning Balance at Dec. 31, 2024 $ 3,475,844 $ 5,206 6,453,606 (1,039,338) (2,584) (1,951,067) 10,021
Net income (loss) 1,290     1,005     285
Distributions to noncontrolling interest (1,892)           (1,892)
Foreign currency translation adjustment (289)       (289)    
Vesting of restricted stock units (in shares)   970,000          
Vesting of restricted stock units 0 $ 10 (10)        
Stock-based compensation 12,289   12,289        
Payment of cash dividends (30,877)     (30,877)      
Dividend equivalents (665)     (665)      
Purchase of treasury stock (20,295)         (20,295)  
Ending Balance (in shares) at Mar. 31, 2025   521,755,000          
Ending Balance at Mar. 31, 2025 $ 3,435,405 $ 5,216 6,465,885 (1,069,875) (2,873) (1,971,362) 8,414
Beginning Balance (in shares) at Dec. 31, 2024 520,784,783 520,785,000          
Beginning Balance at Dec. 31, 2024 $ 3,475,844 $ 5,206 6,453,606 (1,039,338) (2,584) (1,951,067) 10,021
Net income (loss) (83,857)            
Foreign currency translation adjustment $ 759            
Ending Balance (in shares) at Sep. 30, 2025 523,642,586 523,642,000          
Ending Balance at Sep. 30, 2025 $ 3,255,085 $ 5,235 6,484,104 (1,217,668) (1,825) (2,021,041) 6,280
Beginning Balance (in shares) at Mar. 31, 2025   521,755,000          
Beginning Balance at Mar. 31, 2025 3,435,405 $ 5,216 6,465,885 (1,069,875) (2,873) (1,971,362) 8,414
Net income (loss) (48,697)     (49,144)     447
Distributions to noncontrolling interest (2,533)           (2,533)
Foreign currency translation adjustment 1,848       1,848    
Vesting of restricted stock units (in shares)   1,789,000          
Vesting of restricted stock units 0 $ 18 (18)        
Stock-based compensation 9,578   9,578        
Payment of cash dividends (30,742)     (30,742)      
Dividend equivalents (415)     (415)      
Purchase of treasury stock (15,771)         (15,771)  
Ending Balance (in shares) at Jun. 30, 2025   523,544,000          
Ending Balance at Jun. 30, 2025 3,348,673 $ 5,234 6,475,445 (1,150,176) (1,025) (1,987,133) 6,328
Net income (loss) (36,450)     (36,402)     (48)
Foreign currency translation adjustment (800)       (800)    
Vesting of restricted stock units (in shares)   98,000          
Vesting of restricted stock units 0 $ 1 (1)        
Stock-based compensation 8,660   8,660        
Payment of cash dividends (30,495)     (30,495)      
Dividend equivalents (595)     (595)      
Purchase of treasury stock $ (33,908)         (33,908)  
Ending Balance (in shares) at Sep. 30, 2025 523,642,586 523,642,000          
Ending Balance at Sep. 30, 2025 $ 3,255,085 $ 5,235 $ 6,484,104 $ (1,217,668) $ (1,825) $ (2,021,041) $ 6,280